Hecht David W
Hines Veterans' Affairs Hospital, Hines, USA.
Clin Infect Dis. 2004 Jul 1;39(1):92-7. doi: 10.1086/421558. Epub 2004 Jun 3.
Antibiotic-resistant anaerobic bacteria have become increasingly recognized as a confounding factor in the selection of therapeutic agents. The use of potent, broad-spectrum antibiotics as empirical therapy, along with appropriate adjunctive measures, has, in some ways, masked the magnitude of the antibiotic resistance problem that parallels that observed for nonanaerobic pathogens. The use of standardized testing methods that recognize resistance and an understanding of resistance mechanisms have become essential for the treatment of patients and the development of new agents.
抗生素耐药性厌氧菌已日益被视为治疗药物选择中的一个混杂因素。使用强效广谱抗生素作为经验性治疗手段,再加上适当的辅助措施,在某种程度上掩盖了与非厌氧性病原体类似的抗生素耐药性问题的严重程度。采用能够识别耐药性的标准化检测方法以及对抗药机制的了解,对于患者治疗和新药研发已变得至关重要。